Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 147 Melanoma 122 Breast Neoplasms 98 Squamous Cell Carcinoma of Head and Neck 96 Triple Negative Breast Neoplasms 85 Lung Neoplasms 64 Neoplasm Metastasis 53 Carcinoma, Renal Cell 49 Neoplasms 46 Head and Neck Neoplasms 46 Colorectal Neoplasms 41 Ovarian Neoplasms 38 Carcinoma, Transitional Cell 38 Carcinoma, Hepatocellular 36 Urinary Bladder Neoplasms 35 Pancreatic Neoplasms 35 Recurrence 33 Stomach Neoplasms 32 Glioblastoma 30 Brain Neoplasms 28 Sarcoma 26 Endometrial Neoplasms 25 Prostatic Neoplasms 23 Hodgkin Disease 22 Uterine Cervical Neoplasms 19 Fallopian Tube Neoplasms 19 Carcinoma, Squamous Cell 19 Esophageal Squamous Cell Carcinoma 17 Adenocarcinoma 17 Multiple Myeloma 16

Interventions

pembrolizumab 1 osimertinib 1 binimetinib 1 Pemetrexed 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Non-small Cell Carcinoma × pembrolizumab × Clear all

NCT03991819 2025-12-05

BiniPembro

University Health Network, Toronto

Phase 1 Recruiting

Non-small Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡